MICHAEL C JAMES Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL C JAMES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL C JAMES. MICHAEL C JAMES is Director in GUIDED THERAPEUTICS INC ($SPRX) and Chief Financial Officer in Terra Tech Corp. ($TRTC).
Latest Insider Trading Transactions of MICHAEL C JAMES
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2015 | TRTC | Terra Tech Corp. | JAMES MICHAEL C | Chief Financial Off ... | Option Exercise | P | 0.00 | 200,000 | 0 | 200,000 | |
| Jul 14 2014 | TRTC | Terra Tech Corp. | JAMES MICHAEL C | Chief Financial Off ... | Grant | A | 0.00 | 490,196 | 0 | 790,196 | 300 K to 790.2 K (+163.40 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 10,000 | 7,100 | 348,368 | 358.4 K to 348.4 K (-2.79 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 12,500 | 8,875 | 358,368 | 370.9 K to 358.4 K (-3.37 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 10,000 | 7,000 | 370,868 | 380.9 K to 370.9 K (-2.63 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.73 | 2,500 | 1,828 | 380,868 | 383.4 K to 380.9 K (-0.65 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 1,000 | 840 | 383,368 | 384.4 K to 383.4 K (-0.26 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 11,500 | 9,775 | 384,368 | 395.9 K to 384.4 K (-2.91 %) |
| Aug 10 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 6,500 | 5,460 | 395,868 | 402.4 K to 395.9 K (-1.62 %) |
| Aug 10 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 6,000 | 5,100 | 402,368 | 408.4 K to 402.4 K (-1.47 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 4,600 | 4,140 | 408,368 | 413 K to 408.4 K (-1.11 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.93 | 100 | 93 | 412,968 | 413.1 K to 413 K (-0.02 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 7,560 | 7,106 | 413,068 | 420.6 K to 413.1 K (-1.80 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.95 | 240 | 228 | 420,628 | 420.9 K to 420.6 K (-0.06 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.85 | 54,429 | 46,265 | 1,736,574 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.65 | 54,429 | 35,379 | 1,682,145 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.00 | 54,430 | 0 | 1,627,716 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.85 | 51,282 | 43,590 | 1,573,286 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.65 | 51,282 | 33,333 | 1,522,004 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.00 | 51,282 | 0 | 1,470,722 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | D | 0.65 | 163,288 | 106,137 | 1,419,440 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | D | 0.65 | 153,846 | 100,000 | 1,582,728 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 12,500 | 10,625 | 420,868 | 433.4 K to 420.9 K (-2.88 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 3,300 | 2,274 | 433,368 | 436.7 K to 433.4 K (-0.76 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 9,700 | 6,693 | 436,668 | 446.4 K to 436.7 K (-2.17 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 5,300 | 3,657 | 446,368 | 451.7 K to 446.4 K (-1.17 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.60 | 3,100 | 1,860 | 451,668 | 454.8 K to 451.7 K (-0.68 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 1,100 | 770 | 454,768 | 455.9 K to 454.8 K (-0.24 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,763 | 455,868 | 458.4 K to 455.9 K (-0.55 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 12,500 | 9,500 | 458,368 | 470.9 K to 458.4 K (-2.65 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.65 | 6,500 | 4,225 | 470,868 | 477.4 K to 470.9 K (-1.36 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.68 | 7,565 | 5,106 | 477,368 | 484.9 K to 477.4 K (-1.56 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.68 | 1,935 | 1,316 | 484,933 | 486.9 K to 484.9 K (-0.40 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 1,500 | 1,035 | 486,868 | 488.4 K to 486.9 K (-0.31 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 1,000 | 690 | 488,368 | 489.4 K to 488.4 K (-0.20 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 5,500 | 3,850 | 489,368 | 494.9 K to 489.4 K (-1.11 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,500 | 4,125 | 494,868 | 500.4 K to 494.9 K (-1.10 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 500 | 380 | 500,368 | 500.9 K to 500.4 K (-0.10 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 4,000 | 3,000 | 500,868 | 504.9 K to 500.9 K (-0.79 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 3,500 | 2,660 | 504,868 | 508.4 K to 504.9 K (-0.69 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 5,000 | 3,850 | 508,368 | 513.4 K to 508.4 K (-0.97 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 12,500 | 9,625 | 513,368 | 525.9 K to 513.4 K (-2.38 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.62 | 10,000 | 6,200 | 525,868 | 535.9 K to 525.9 K (-1.87 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.65 | 2,500 | 1,625 | 535,868 | 538.4 K to 535.9 K (-0.46 %) |
| May 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 3,900 | 2,906 | 538,368 | 542.3 K to 538.4 K (-0.72 %) |
| May 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,500 | 1,888 | 542,268 | 544.8 K to 542.3 K (-0.46 %) |
| May 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 6,100 | 4,612 | 544,768 | 550.9 K to 544.8 K (-1.11 %) |
| May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,500 | 1,898 | 550,868 | 553.4 K to 550.9 K (-0.45 %) |
| May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,900 | 2,204 | 553,368 | 556.3 K to 553.4 K (-0.52 %) |
| May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 2,500 | 1,923 | 556,268 | 558.8 K to 556.3 K (-0.45 %) |
| May 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.78 | 4,600 | 3,588 | 558,768 | 563.4 K to 558.8 K (-0.82 %) |
| May 15 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 12,500 | 10,375 | 563,368 | 575.9 K to 563.4 K (-2.17 %) |
| May 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 7,100 | 5,680 | 575,868 | 583 K to 575.9 K (-1.22 %) |
| May 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 5,400 | 4,482 | 582,968 | 588.4 K to 583 K (-0.92 %) |
| Apr 24 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 4,600 | 3,818 | 588,368 | 593 K to 588.4 K (-0.78 %) |
| Apr 24 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 2,500 | 2,088 | 592,968 | 595.5 K to 593 K (-0.42 %) |
| Apr 24 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 5,400 | 4,536 | 595,468 | 600.9 K to 595.5 K (-0.90 %) |
| Apr 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 7,500 | 6,338 | 600,868 | 608.4 K to 600.9 K (-1.23 %) |
| Apr 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 5,000 | 4,250 | 608,368 | 613.4 K to 608.4 K (-0.82 %) |
| Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 2,500 | 2,075 | 613,368 | 615.9 K to 613.4 K (-0.41 %) |
| Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 4,700 | 3,943 | 615,868 | 620.6 K to 615.9 K (-0.76 %) |
| Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 1,000 | 850 | 620,568 | 621.6 K to 620.6 K (-0.16 %) |
| Apr 18 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.86 | 4,300 | 3,698 | 621,568 | 625.9 K to 621.6 K (-0.69 %) |
| Apr 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 12,500 | 11,250 | 625,868 | 638.4 K to 625.9 K (-1.96 %) |
| Mar 29 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.89 | 12,500 | 11,125 | 638,368 | 650.9 K to 638.4 K (-1.92 %) |
| Mar 20 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.96 | 12,500 | 12,000 | 650,868 | 663.4 K to 650.9 K (-1.88 %) |
| Mar 16 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.98 | 12,500 | 12,250 | 663,368 | 675.9 K to 663.4 K (-1.85 %) |
| Mar 07 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.88 | 8,600 | 7,568 | 675,868 | 684.5 K to 675.9 K (-1.26 %) |
| Mar 07 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 3,900 | 3,510 | 684,468 | 688.4 K to 684.5 K (-0.57 %) |
| Mar 02 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 12,500 | 9,400 | 688,368 | 700.9 K to 688.4 K (-1.78 %) |
| Feb 22 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 7,500 | 5,175 | 700,868 | 708.4 K to 700.9 K (-1.06 %) |
| Feb 22 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,500 | 1,748 | 708,368 | 710.9 K to 708.4 K (-0.35 %) |
| Feb 22 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,500 | 1,750 | 710,868 | 713.4 K to 710.9 K (-0.35 %) |
| Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,500 | 1,745 | 713,368 | 715.9 K to 713.4 K (-0.35 %) |
| Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 5,000 | 3,500 | 715,868 | 720.9 K to 715.9 K (-0.69 %) |
| Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,763 | 720,868 | 723.4 K to 720.9 K (-0.35 %) |
| Feb 17 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,775 | 723,368 | 725.9 K to 723.4 K (-0.34 %) |
| Feb 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 2,900 | 2,001 | 725,868 | 728.8 K to 725.9 K (-0.40 %) |
| Feb 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 16,500 | 11,468 | 728,768 | 745.3 K to 728.8 K (-2.21 %) |
| Feb 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 5,600 | 3,920 | 745,268 | 750.9 K to 745.3 K (-0.75 %) |
| Jan 30 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.68 | 10,000 | 6,800 | 750,868 | 760.9 K to 750.9 K (-1.31 %) |
| Jan 30 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 2,500 | 1,725 | 760,868 | 763.4 K to 760.9 K (-0.33 %) |
| Jan 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.42 | 9,500 | 13,490 | 763,368 | 772.9 K to 763.4 K (-1.23 %) |
| Jan 25 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.43 | 3,000 | 4,290 | 772,868 | 775.9 K to 772.9 K (-0.39 %) |
| Jan 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.68 | 500 | 840 | 777,868 | 778.4 K to 777.9 K (-0.06 %) |
| Jan 13 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.69 | 10,000 | 16,900 | 778,368 | 788.4 K to 778.4 K (-1.27 %) |
| Jan 09 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.77 | 4,500 | 7,965 | 788,368 | 792.9 K to 788.4 K (-0.57 %) |
| Jan 09 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.78 | 8,000 | 14,240 | 792,868 | 800.9 K to 792.9 K (-1.00 %) |
| Jan 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.40 | 6,648 | 9,307 | 800,868 | 807.5 K to 800.9 K (-0.82 %) |
| Jan 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.42 | 4,142 | 5,882 | 807,516 | 811.7 K to 807.5 K (-0.51 %) |
| Jan 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.45 | 1,710 | 2,480 | 811,658 | 813.4 K to 811.7 K (-0.21 %) |
| Dec 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.50 | 10,000 | 15,000 | 813,368 | 823.4 K to 813.4 K (-1.21 %) |
| Dec 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.50 | 1,800 | 2,700 | 823,368 | 825.2 K to 823.4 K (-0.22 %) |
| Dec 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.47 | 700 | 1,029 | 825,168 | 825.9 K to 825.2 K (-0.08 %) |
| Dec 02 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.93 | 3,700 | 3,441 | 850,868 | 854.6 K to 850.9 K (-0.43 %) |
| Dec 02 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.95 | 8,800 | 8,360 | 854,568 | 863.4 K to 854.6 K (-1.02 %) |
| Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.34 | 2,071 | 2,775 | 825,868 | 827.9 K to 825.9 K (-0.25 %) |
| Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Buy | D | 1.33 | 6,379 | 8,484 | 827,939 | 821.6 K to 827.9 K (+0.78 %) |
| Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.32 | 2,500 | 3,300 | 834,318 | 836.8 K to 834.3 K (-0.30 %) |
| Dec 14 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 1.30 | 1,550 | 2,015 | 836,818 | 838.4 K to 836.8 K (-0.18 %) |
| Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | M | 0.78 | 25,000 | 19,500 | 51,250 | |
| Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 10,000 | 9,400 | 863,368 | 873.4 K to 863.4 K (-1.14 %) |
| Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 2,500 | 2,350 | 873,368 | 875.9 K to 873.4 K (-0.29 %) |
| Nov 28 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Buy | M | 0.00 | 37,500 | 0 | 63,750 | 26.3 K to 63.8 K (+142.86 %) |
| Dec 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.96 | 12,500 | 12,000 | 838,368 | 850.9 K to 838.4 K (-1.47 %) |
| Nov 18 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 6,400 | 5,760 | 875,868 | 882.3 K to 875.9 K (-0.73 %) |
| Nov 18 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 6,100 | 5,490 | 882,268 | 888.4 K to 882.3 K (-0.69 %) |
| Nov 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 8,500 | 6,375 | 900,868 | 909.4 K to 900.9 K (-0.93 %) |
| Nov 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 4,000 | 3,080 | 909,368 | 913.4 K to 909.4 K (-0.44 %) |
| Nov 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.92 | 1,500 | 1,380 | 888,368 | 889.9 K to 888.4 K (-0.17 %) |
| Nov 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 11,000 | 10,340 | 889,868 | 900.9 K to 889.9 K (-1.22 %) |
| Nov 01 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,763 | 913,368 | 915.9 K to 913.4 K (-0.27 %) |
| Nov 01 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 10,000 | 7,000 | 915,868 | 925.9 K to 915.9 K (-1.08 %) |
| Oct 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 6,500 | 4,875 | 925,868 | 932.4 K to 925.9 K (-0.70 %) |
| Oct 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 3,500 | 2,660 | 932,368 | 935.9 K to 932.4 K (-0.37 %) |
| Oct 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 2,500 | 1,925 | 935,868 | 938.4 K to 935.9 K (-0.27 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,500 | 4,125 | 938,368 | 943.9 K to 938.4 K (-0.58 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 5,000 | 3,800 | 943,868 | 948.9 K to 943.9 K (-0.53 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 2,000 | 1,540 | 948,868 | 950.9 K to 948.9 K (-0.21 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 2,300 | 1,610 | 950,868 | 953.2 K to 950.9 K (-0.24 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.73 | 1,200 | 876 | 953,168 | 954.4 K to 953.2 K (-0.13 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.74 | 2,500 | 1,850 | 954,368 | 956.9 K to 954.4 K (-0.26 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,000 | 3,750 | 956,868 | 961.9 K to 956.9 K (-0.52 %) |
| Oct 13 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 1,500 | 1,200 | 961,868 | 963.4 K to 961.9 K (-0.16 %) |
| Oct 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.78 | 6,250 | 4,875 | 963,368 | 969.6 K to 963.4 K (-0.64 %) |
| Oct 03 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 6,250 | 4,813 | 969,618 | 975.9 K to 969.6 K (-0.64 %) |
| Sep 27 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 5,500 | 4,400 | 975,868 | 981.4 K to 975.9 K (-0.56 %) |
| Sep 27 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.83 | 7,000 | 5,810 | 981,368 | 988.4 K to 981.4 K (-0.71 %) |
| Sep 16 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.89 | 12,500 | 11,125 | 988,368 | 1 M to 988.4 K (-1.25 %) |
| Sep 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.87 | 3,189 | 2,774 | 1,000,868 | 1 M to 1 M (-0.32 %) |
| Sep 09 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.89 | 9,311 | 8,287 | 1,004,057 | 1 M to 1 M (-0.92 %) |
| Sep 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 3,950 | 3,713 | 1,013,368 | 1 M to 1 M (-0.39 %) |
| Sep 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.93 | 6,700 | 6,231 | 1,017,318 | 1 M to 1 M (-0.65 %) |
| Sep 06 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.92 | 1,850 | 1,702 | 1,024,018 | 1 M to 1 M (-0.18 %) |
| Aug 24 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.81 | 12,500 | 10,125 | 1,026 | 13.5 K to 1 K (-92.41 %) |
| Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.79 | 3,677 | 2,905 | 1,038,368 | 1 M to 1 M (-0.35 %) |
| Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 4,623 | 3,698 | 1,042,045 | 1 M to 1 M (-0.44 %) |
| Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 4,000 | 3,200 | 1,046,668 | 1.1 M to 1 M (-0.38 %) |
| Aug 19 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.80 | 200 | 160 | 1,050,668 | 1.1 M to 1.1 M (-0.02 %) |
| Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,300 | 3,975 | 1,050,868 | 1.1 M to 1.1 M (-0.50 %) |
| Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 2,500 | 1,900 | 1,056,168 | 1.1 M to 1.1 M (-0.24 %) |
| Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.78 | 2,800 | 2,184 | 1,058,668 | 1.1 M to 1.1 M (-0.26 %) |
| Aug 15 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.79 | 1,900 | 1,501 | 1,061,468 | 1.1 M to 1.1 M (-0.18 %) |
| Aug 04 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 400 | 340 | 1,063,368 | 1.1 M to 1.1 M (-0.04 %) |
| Aug 04 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.86 | 12,100 | 10,406 | 1,063,768 | 1.1 M to 1.1 M (-1.12 %) |
| Aug 01 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 12,500 | 11,250 | 1,075,868 | 1.1 M to 1.1 M (-1.15 %) |
| Jul 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.88 | 7,500 | 6,600 | 1,088,368 | 1.1 M to 1.1 M (-0.68 %) |
| Jul 22 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.87 | 5,000 | 4,350 | 1,095,868 | 1.1 M to 1.1 M (-0.45 %) |
| Jul 11 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.98 | 12,500 | 12,250 | 1,100,868 | 1.1 M to 1.1 M (-1.12 %) |
| Jul 11 2011 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 9,900 | 9,306 | 1,113,568 | 1.1 M to 1.1 M (-0.88 %) |